Search Videos and More
Video
Women treating high risk indicated patients (WHiP) conference
In April 2024, WellSpan York Hospital hosted the second annual Women Treating High Risk Indicated Patients (WHiP) conference, bringing together 21 female cardiologists while streaming to more than 75 cardiologists in five countries
News
Maximizing VAD benefits: The critical role of timely referral
Many heart failure patients who need a ventricular assist device (VAD) don’t get one until their condition has advanced too far. Learn the nuances of advanced heart failure symptoms and when to refer patients for VAD evaluation.
News
Catching abdominal aortic aneurysms before they burst
An abdominal aortic aneurysm (AAA) screening is recommended for men ages 65-75 who are or were smokers. Women with risk factors like a family history may also benefit. Find out who to screen for AAA, how to manage it and when to refer.
News
Should we do genetic screening for CVD and other diseases?
Screening asymptomatic patients for CVD-causing genes can save lives, but many scientific and ethical questions must be answered before we know it’s worth it.
News
One-of-a-kind stroke prevention for patients with Afib
WellSpan is the first-in-the-US to anchor an in-lab 4D-CT imaging modality to ensure devices are positioned properly.
News
TAVR Q&A with Dr. James Harvey
Dr. Harvey is the “doctor that other doctors come to” to learn the most advanced technique for TAVR. He’s been all over the world, in fact, teaching other interventional cardiologists his approach, which has become the standard of care for this procedure.
News
4D-CT for heart disease diagnosis
Cardiologists at WellSpan York Hospital are working to change the standard of care for patients with heart complaints thanks to a new 4D cardiac CT scan machine.
News
Leading-edge treatments for structural heart disease
WellSpan Health is a regional leader in the treatment of structural heart disease, offering enhanced techniques for transcatheter aortic valve replacement (TAVR) and for implanting the WATCHMAN device for left atrial appendage closure.
News
WellSpan cardiologists using sound waves to unblock arteries
WellSpan cardiologists now can open up severely calcified heart blockages with a new tool: sound waves.
News
Excellence in chronic total occlusion treatment
Percutaneous coronary intervention (PCI) can help many patients with CTO who are experiencing severe shortness of breath and chest discomfort.
News
Ultramodern care for inherited cardiovascular diseases
WellSpan Health’s Center for Inherited Cardiovascular Diseases offers the latest, most advanced treatments for genetic cardiac disorders through precision medicine, novel approaches, genetic testing, advanced research and a multidisciplinary team approach.
News
Paving the way for optimal LAAO procedure outcomes
WellSpan health is a national leader in left atrial appendage occlusion (LAAO) research, technology and procedures. Their aim is to reduce stroke risk in atrial fibrillation (Afib) patients who are not amenable to anticoagulation.